Northwestern Medicine scientists have discovered an epigenetic imbalance that can lead to cancer, and used these findings to inhibit tumors in models.
Browsing: Clinical Breakthroughs
Drugs commonly used to prevent HIV transmission from mother to child during pregnancy were not associated with a higher risk of adverse birth outcomes, according to a new study.
Northwestern Medicine scientists have discovered a new compound that halts the spread of multiple types of cancer cells.
On May 6, the Illinois Precision Medicine Consortium hosted a launch event at Chicago’s Millennium Park, one of many simultaneous events held around the country to mark the program’s launch.
NewCures at Northwestern University is a novel accelerator working to identify promising potential therapies in development, fund research into their viability, and promote their development as new drugs.
Within the Institute for Public Health and Medicine (IPHAM), investigators collaborate at the intersection of public health and medicine — connecting clinics to communities and accelerating innovations that impact the health of both patients and populations.
The addition of a chemotherapy drug to adjuvant hormone therapy did not improve survival for patients with high-risk prostate cancer, according to a new study.
A home-based exercise program, consisting of wearables and telephone coaching, did not improve walking endurance for patients with peripheral artery disease, according to a study published in JAMA.
In new clinical trials, a gene therapy for a serious blood disorder called beta-thalassemia significantly improved outcomes among patients, without serious side effects.
A new study shows a patient’s overall heart disease risk assessment can better determine blood pressure treatment, as opposed to examining blood pressure levels alone.